ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,287.60
      0.00%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      80.425
      -0.24%
      Bitcoin
      92,885.58
      -1.70%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Manolete Partners Plc (MANO) Quote

      Manolete Partners Plc

      Manolete Partners Plc (MANO)

      LSE
      83.00
      0.00
      ( 0.00% )
      Updated: 03:00:24
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      83.00
      Bid
      81.00
      Ask
      85.00
      Volume
      0.00
      81.00 Day's Range 83.00
      80.50 52 Week Range 180.00
      Market Cap
      36.322M
      Previous Close
      83.00
      Open
      83.00
      Last Trade
      (O)
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      22,283
      Shares Outstanding
      43,761,305
      Dividend Yield
      -
      PE Ratio
      38.97
      Earnings Per Share (EPS)
      0.02
      Revenue
      26.3M
      Net Profit
      933k

      About Manolete Partners Plc

      Sector
      Legal Services
      Industry
      Legal Services
      Website
      www.manolete-partners.com
      Headquarters
      Buckinghamshire, Gbr
      Founded
      -
      Manolete Partners Plc is listed in the Legal Services sector of the London Stock Exchange with ticker MANO. The last closing price for Manolete Partners was 83p. Over the last year, Manolete Partners shares have traded in a share price range of 80.50p to 180.00p.

      Manolete Partners currently has 43,761,305 shares outstanding. The market capitalization of Manolete Partners is £36.32 million. Manolete Partners has a price to earnings ratio (PE ratio) of 38.97.

      Ask ADVFN Intelligence (AI)

      MANO Latest News

      More News

      Manolete Partners PLC Block Listing Six Monthly Return

      Manolete Partners PLC 29 November 2024   29 November 2024   Manolete Partners Plc   ("Manolete" or the "Company")   Block Listing Six Monthly Return   Date: 29 November 2024   Name of...

      November 29 2024
      RNS Regulatory News

      CORRECT: Manolete Partners swings to loss thanks to increased expenses

      elling of "case".) (Alliance News) - Manolete Partners PLC on Tuesday said it swung to a loss in the first half of it ...

      November 19 2024
      Alliance News

      Manolete Partners swings to interim loss thanks to increased expenses

      Manolete Partners PLC on Tuesday said it swung to a loss in the first half of its current financial year despite reve ...

      November 19 2024
      Alliance News

      Manolete Partners PLC Half-year Report

      Manolete Partners PLC 19 November 2024   19 November 2024   MANOLETE PARTNERS PLC ("Manolete" or the "Company")   Half-year results for the six months ended 30 September 2024 Manolete...

      November 19 2024
      RNS Regulatory News

      Manolete Partners PLC Manolete named FT Growth Champion

      Manolete Partners PLC 01 November 2024   1 November 2024 ​   Manolete Partners Plc   ("Manolete" or the "Company") Manolete Partners Plc named as a Financial Times Europe Long-Term Growth...

      November 01 2024
      RNS Non-Regulatory

      Manolete Partners PLC Notice of Results

      Manolete Partners PLC 24 October 2024       24 October 2024   Manolete Partners PLC ("Manolete" or the "Company")   Notice of Interim Results     Manolete (AIM: MANO), the leading UK-listed...

      October 24 2024
      RNS Regulatory News

      Manolete Partners PLC Director/PDMR Shareholding

      Manolete Partners PLC 17 October 2024   17 October 2024   Manolete Partners PLC ("Manolete" or the "Company")   Director/PDMR Dealings   Manolete Partners Plc (AIM:MANO), the leading quoted UK...

      October 17 2024
      RNS Regulatory News

      Manolete Partners PLC Result of AGM

      Manolete Partners PLC 30 September 2024   30 September 2024 ​   Manolete Partners Plc   ("Manolete" or the "Company") Result of AGM   ​ Manolete (AIM:MANO), the leading UK-listed insolvency...

      September 30 2024
      RNS Regulatory News

      Manolete Partners PLC Grant of Share Options

      Manolete Partners PLC 20 September 2024   20 September 2024   Manolete Partners plc ("Manolete" or the "Company") Grant of Share Options   Manolete, a leading UK insolvency litigation...

      September 20 2024
      RNS Regulatory News

      Manolete Partners PLC Posting of Annual Report and Notice of AGM

      Manolete Partners PLC 06 September 2024   6 September 2024 ​ Manolete Partners Plc   ("Manolete" or the "Company")   Posting of Annual Report and Notice of AGM ​   Manolete (AIM:MANO), the...

      September 06 2024
      RNS Regulatory News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-4-4.597701149438787.580.52151983.85100421DE
      4-5.5-6.2146892655488.59080.51158085.41804374DE
      12-14-14.432989690797117.580.52228399.38377417DE
      26-49.5-37.358490566132.5147.580.524352113.08482553DE
      52-97-53.888888888918018080.519791121.4528504DE
      156-189.5-69.5412844037272.533080.517992196.83823347DE
      260-337-80.238095238142060080.539543251.03074046DE

      MANO - Frequently Asked Questions (FAQ)

      What is the current Manolete Partners share price?
      The current share price of Manolete Partners is 83.00p
      How many Manolete Partners shares are in issue?
      Manolete Partners has 43,761,305 shares in issue
      What is the market cap of Manolete Partners?
      The market capitalisation of Manolete Partners is GBP 36.32M
      What is the 1 year trading range for Manolete Partners share price?
      Manolete Partners has traded in the range of 80.50p to 180.00p during the past year
      What is the PE ratio of Manolete Partners?
      The price to earnings ratio of Manolete Partners is 38.97
      What is the cash to sales ratio of Manolete Partners?
      The cash to sales ratio of Manolete Partners is 1.38
      What is the reporting currency for Manolete Partners?
      Manolete Partners reports financial results in GBP
      What is the latest annual turnover for Manolete Partners?
      The latest annual turnover of Manolete Partners is GBP 26.3M
      What is the latest annual profit for Manolete Partners?
      The latest annual profit of Manolete Partners is GBP 933k
      What is the registered address of Manolete Partners?
      The registered address for Manolete Partners is 2-4 PACKHORSE ROAD, GERRARDS CROSS, BUCKINGHAMSHIRE, SL9 7QE
      What is the Manolete Partners website address?
      The website address for Manolete Partners is www.manolete-partners.com
      Which industry sector does Manolete Partners operate in?
      Manolete Partners operates in the LEGAL SERVICES sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TM1Technology Minerals Plc
      0.15p
      (25.00%)
      		11.48M
      MASTMast Energy Developments Plc
      0.205p
      (17.14%)
      		7.65M
      OMIOrosur Mining Inc
      8.25p
      (17.02%)
      		180.01k
      NFXNuformix Plc
      0.07p
      (16.67%)
      		15.44M
      ZIOCZanaga Iron Ore Company Limited
      8.66p
      (9.76%)
      		22.07k
      VRSVersarien Plc
      0.03p
      (-16.67%)
      		134.87k
      THSTharisa Plc
      55.50p
      (-14.62%)
      		44.18k
      EYEEagle Eye Solutions Group Plc
      405.00p
      (-14.01%)
      		9.29k
      ZENZenith Energy Ltd.
      5.50p
      (-10.57%)
      		245.98k
      4GBL4global Plc
      45.50p
      (-9.00%)
      		95
      TRPTower Resources Plc
      0.0405p
      (2.53%)
      		95.59M
      CPXCap-xx Limited
      0.155p
      (-4.62%)
      		32.99M
      DGIDg Innovate Plc
      0.0185p
      (-7.50%)
      		23.47M
      NFXNuformix Plc
      0.07p
      (16.67%)
      		15.44M
      ORCPOracle Power Plc
      0.019p
      (0.00%)
      		13.53M

      Discussion

      View Full Feed
      DiamondHealer95 DiamondHealer95 8 minutes ago
      I mean Kim said once they hit 1.5 metric tons they're open for business and they're about halfway there so..... You're a genius! Congrats on the business. I also run one with 100% positive feedback over 22 years so I get the perspective🤪

      Also, in my Arby's voice "I have the
      KBLB
      DiamondHealer95 DiamondHealer95 12 minutes ago
      We've invested similarly
      KBLB
      sunspotter sunspotter 23 minutes ago
      Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
      VPLM
      Flobewan Flobewan 34 minutes ago
      Marc loved your ides
      tinojax tinojax 35 minutes ago
      I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
      PLUG
      mrfence mrfence 37 minutes ago
      Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
      [yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
      FMCC FNMA
      IVRT IVRT 53 minutes ago
      In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
      BMXI
      DewDiligence DewDiligence 53 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      ENTA
      DewDiligence DewDiligence 54 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      Guido2 Guido2 55 minutes ago
      This is DUE DILIGENCE! Thank you Free Fannie.

      https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
      FNMA
      StockItOut StockItOut 1 hour ago
      That Xeriant PR excellently written with bullshit:

      ""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

      "the Company used the data to make several key
      XERI
      gitreal gitreal 1 hour ago
      You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
      BMXI
      RichieBoy RichieBoy 1 hour ago
      Jim wrote a blurb about seeking more US business.

      Help you out any? 🤨
      AFFU
      DesktopDR DesktopDR 1 hour ago
      Any news or updates?
      VPLM
      Tahoe2468 Tahoe2468 1 hour ago
      .0915 by Thursday....... 
      KRTL
      skitahoe skitahoe 1 hour ago
      Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

      According to Google, GBM ha
      NWBO
      fuagf fuagf 1 hour ago
      You are right about the crafty, evil, smart. Authoritarian methods have been in full view
      in capturing America. While we work to do the right things they plot to capture the lot.
      facts_matter14 facts_matter14 1 hour ago
      If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






      .
      SRMX
      StockItOut StockItOut 1 hour ago
      Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
      XERI
      fuagf fuagf 1 hour ago
      He would smother any question with words.
      Shawonsarker84 Shawonsarker84 1 hour ago
      $HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



      https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
      HMBL XTIA
      chen1992 chen1992 2 hours ago
      https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

      https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
      TGLO

      Your Recent History

      LSE
      MANO
      Manolete Partners
      EU
      APHPD
      Assist Public Hopitaux A...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads